Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.14EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EE.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EE.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EE.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EE.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-18639.2US
BQ.1.1.52ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.52ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.52ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.52NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBF.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBF.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBF.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.4.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.4.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.4.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.4.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DS.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DS.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DS.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DS.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.32ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.32NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.58ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.58ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.58ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.58NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.631ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.631ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.631ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.631NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.627ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.627ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.627ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.627NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.519ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.519ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.519ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.519NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.514ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.514ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.514ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.514NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GT.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GT.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GT.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GT.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.87ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used